14th CNSC Sub-Forum "Research Progress and Application of Breast Milk Lycosaccharose" sub-forum was successfully held.

In order to further explore the research progress and application of low polysaccharose in breast milk, the sub-forum on the research progress and application of low polysaccharose in breast milk was held at the 14th National Conference on Nutritional Science and the 11th Asia-Pacific Conference on Clinical Nutrition and the 2nd Global Conference of Chinese Nutrition Scientists.
breast milk lysosaccharose (HMO) is a kind of compound lysosaccharies found in human milk, it is the third largest solid component of human breast milk after lactose and fat, has important physiological functions. HMO can promote the micro-ecological balance of the baby's intestines, promote the proliferation of beneficial bacteria in the intestines, inhibit the growth of harmful bacteria, hinder the proliferation of pathogenic bacteria, regulate the immune system and promote the cognitive development of infants. HMO has become a hot topic in breast milk research at home and abroad in recent years, and has been widely used in infant and young children's products abroad.
sub-forum from Peking University Medical Department, Grenoble University Hospital, Nestle Research Center and other institutions of the top experts made a wonderful academic report, from the production, learning, research from a variety of angles to carry out an overview and analysis, discussed cross-disciplinary, cross-country, cross-industry precision all-round research progress and application, for breast milk low polysaccharose scientific research and application to lay the foundation. The academic discussions of the sub-forums covered the progress of global breast milk research, the focus of breast milk research in China, the clinical study of low polysaccharose in breast milk for infants, children and adults, and the current state of the application of low polysaccharose in breast milk.
The report by Dr. Sagar Thakkar from the Asia division of the Nestle Research Center presents decades of research progress in a variety of breast milk components, including breast milk lysose (HMO), protein, lipids, and energy, and the results of the Nestle Research Center's Breast Milk Research Program (LIFE). Dr Sagar points out that a major focus of breast milk research is the breast milk collection process, and the LIFE study implemented standardized breast milk sample collection and developed and validated more than 20 analytical methods for small amounts of breast milk. It found that breast milk intake, birth age, regional differences, and even circadian rhythms all affect the composition of breast milk.
Yumei Zhang, from Peking University's School of Medicine's School of Public and Health, presents the results of the China Breast Milk Research (MING Study) in collaboration with the Nestle Nutrition Research Institute. Its sample covers eight cities across the country, including more than 540 breast milk mothers. MING research found that not only the content and content of lysose in breast milk varies from person to person, but also china's breast milk microorganisms are very different from other countries, and China's recommendations should be formulated according to the actual situation of breast milk in China.
Jean Pierre, from the University Hospital of Grenoble in France, highlighted the links between the structure and function of a variety of breast milk lysosaccharies. So far, the scientific community has identified more than 200 different structures of breast milk lysose, different breast milk lysose chemical structure determines different functions. The industry's first effort to target breast milk lysose is to synthesize the high levels of major breast milk lyso sugars, such as 2'-FL and LNnt.
Dr. Qin Yan, from BASF's Asia Pacific Market Science Department, describes the efficacy of breast milk lysosaccharides in people other than infants and young children, such as increasing the number of intestinal probiotics, suppressing pathogens, regulating immune function, increasing the digestive tract barrier, regulating intestinal movements, and so on. Dr Qin's report reveals the diversity of the efficacy of low polysaccharose in breast milk and its application in different populations.
Nigel Baldwin, Senior Director of Food and Nutrition at Intertek, introduced the global use of breast milk lysose. A number of countries and regions around the world, including Europe and the United States, have passed safety assessments for breast milk polysaccharose (mainly 2'-FL and LNnt) and are permitted to be added in the appropriate regulations. Since 2017, products containing breast milk polysaccharose have been available in more than 45 countries and territories.Professor Yang Yuxin, Moderator of the
Sub-Forum, Professor Wang Zhixuan
seinding, speaker and field staff photo
This sub-forum is sponsored by the Chinese Nutrition Society, chaired by Professor Yang Yuxin, President of the Chinese Nutrition Society, and Professor Wang Zhixuan, Chairman of the Women's and Children's Nutrition Branch. Nestle (China) Co., Ltd., Wyeth Nutrition (China) Co., Ltd., Glycom A/S, BASF (China) Co., Ltd. supported this sub-forum. About 200 domestic and foreign nutrition researchers and related industry colleagues participated in the forum.
.